1 Doebele RC, "Targeting ALK, ROS1, and BRAF kinases" 7 (7): S375-S376, 2012
2 Soda M, "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer" 448 : 561-566, 2007
3 Choi YL, "EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors" 363 : 1734-1739, 2010
4 Paik JH, "Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma" 76 : 403-409, 2012
5 Kwak EL, "Anaplastic lymphoma kinase inhibition in nonsmall- cell lung cancer" 363 : 1693-1703, 2010
1 Doebele RC, "Targeting ALK, ROS1, and BRAF kinases" 7 (7): S375-S376, 2012
2 Soda M, "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer" 448 : 561-566, 2007
3 Choi YL, "EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors" 363 : 1734-1739, 2010
4 Paik JH, "Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma" 76 : 403-409, 2012
5 Kwak EL, "Anaplastic lymphoma kinase inhibition in nonsmall- cell lung cancer" 363 : 1693-1703, 2010